THE STOCK EXCHANGE OF HONG KONG LIMITED
(A wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited)
Admission of Shanghai Pharmaceuticals Holding Co Ltd and Glencore International plc to List of Designated Securities for Short Selling
The Stock Exchange of Hong Kong Limited, a wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited (HKEx), announces that with effect from 12 July 2011 (Tuesday), Shanghai Pharmaceuticals Holding Co Ltd (Stock code: 2607) and Glencore International plc (Stock code: 805) will be admitted to the list of designated securities eligible for short selling.
The latest list of all designated securities eligible for short selling is available on the HKEx website.
Ends